Evelyn Dorado, md, Viviana Orozco, Maria Victoria Lopez. FUNDACION VALLE DEL LILI
INTRODUCTION: Obesity-related diseases (ORD) are associated with a decrease in the quality of life and life expectancy in patients with morbid obesity and cost of health services produce a impact in the economy.
MAIN: to evaluate the resolution of the principal combordities linked to obesity and their resolution in patients undergoing bariatric surgery.
METHODS: A preliminary retrospective analysis of patients with morbid obesity who received bariatric surgery between january 2014 and January 2016. Comorbilities: hypertension, diabetes mellitus, dyslipidemia, sleep apnea and hypoapnea syndrome (OSAHS) or hepatic steatosis. All the patients had two surgical options: LSG or LRYGB. Follow up was performed each 3 moths per the first year after surgery recording data such as the initial weight, weight loss expressed in percentage of excess weight lost (%EWL) and the percentage of total body weight lost and partial or total resolution of the comorbidity associated with obesity.
RESULTS: We reviewed the records of 136 patients who received bariatric surgery in the institution. Those patients without ORD were excluded. We selected 23 patients with previously documented metabolic disease. 52% (12) were females and the average age was 44±13 years; there were 17 (74%) GS and 6 (26%) LRYGB. The average initial BMI was 43±4.3 kg/m², the %EWL at one month, 6 and 12 months was 35.4±15.2, 62.5±17.5 and 79.1±20.2 respectively. The management of their comorbidities were found in 95.6% of patients (22), partial recovery in 32% and complete recovery in 68%. 52.1% of referrals were reported in the first month post-surgery.
CONCLUSION: Bariatric surgery has proved to be the most effective method for reducing and sustaining weight loss in the long term. These results are linked to close follow-ups and changes in dietary habits and patterns of physical activity on the part of the patient. The benefit of the surgery includes improvements in the quality of life and in the resolution of comorbidities secondary to obesity, both of which decrease the risk of an adverse cardiovascular event. The resolution of partial or total comorbidities depends, to a great extent, on a timely diagnosis and the treatment of diseases; the earlier the interventions, the greater the possibility of a cure. It is very clear, from the results of this work, that a decrease of 50% of the patient’s excess weight has a positive impact in terms of discontining medications, normalizing the patient’s biochemical profile and extending the patient’s life expectancy.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 77773
Program Number: P540
Presentation Session: Poster (Non CME)
Presentation Type: Poster
